| Prev Close | 162.97 |
| Day Low/High | 159.78 / 162.93 |
| 52 Wk Low/High | 133.65 / 173.65 |
Johnson & Johnson (JNJ)
161.25
NYSE
| Exchange | NYSE |
| Shares Outstanding | 2632.71B |
| Market Cap | 429.05B |
| P/E Ratio | 28.74 |
| Div & Yield | N.A. (N.A) |
Latest News
Jim Cramer: Robbing Peter to Pay Paul
Let's review this Archegos drama and some lessons from this fickle market.
Should You Buy AstraZeneca After Its Positive Vaccine News?
Here's my view on this space and where the money is to be made.
Spring Ahead or Fall Back? No Fear, Nasdaq Uptrend, Trading AbbVie and AMD
COVID numbers stopped improving a while ago, even with ever-improving rates of vaccination. Just what is going on here?
Jim Cramer: Want to Put Your Stimulus Check Into Stocks? Read This First
Let's set out the case for stocks -- and which kind -- and whether you might want to pay down other debt first.
Jim Cramer: Go Ahead, Try and Bet Against Me
You can listen to the haters on Twitter and Reddit, or you can see what I've been doing since 1979: trying to help the average Joe make some money.
Deceptive Thursday, Rotational Roundabout, Biden Bits, Disparate Fed Data
Plus, the efficacy rate of the still-pending Novavax Covid-19 vaccine against variants of the virus give reason for pause.
Economic Stimulus, Financial Markets React, Treasury Auctions, Covid Update
How does this all end? I don't know that it does end.
Emergent BioSolutions Turns Bearish, So Beware
A break in a key support level could precipitate further declines in the life sciences company's shares.
Steepening Yield Curve, All-Star Stocks Beatdown, Fed Speak, S&P Rally?
Smaller to mid-cap names have fared somewhat better than large cap tech, but make no mistake... there is a circle of life/death here.
Stopped Out on Johnson & Johnson but Willing to Buy it Lower
Stand aside for now.
Biden Bits, Vaccine Vanguard, Unmasking Folly, Minerd Musings, Ives Inklings
Among other things, the president works to align Democratic senators to support his massive Covid relief bill.
Jim Cramer: The Rush to Reopen Is Ill-Advised
Only 7% of Texas is vaccinated, or two million people. I don't want to mess with Texas or Texans until that number is higher.
I'm Looking at Setups in Microsoft and Johnson & Johnson
Let's see what happens with these buy zones for both MSFT and JNJ.
What's Up at the Fed? Supply & Demand, 12 Trading Notes, Microsoft Conference
Should we care about Australia's central bank taking overtly aggressive action to reign in the long end of their yield curve? Yes, we should.
Broad Rally, Vaccine Optimism, Johnson & Johnson, GameStop Roars, Trading Nvidia
The market's catalyst had everything to do with the virus... optimism that humankind might stuff that scourge back into Pandora's box.
The Suppressed Economy, Impressive Earnings, U.S. Treasury Curve, Pandemic Watch
I want you to think about how quickly the long end of the U.S. Treasury curve is moving.
Here's Why I'm All in on the 'Normalization' Trade
No matter what you want to call it -- there are plenty of reasons to be bullish right now.
Short Story Ends, Watching Curves, Enter J&J, Flexible FDA, Ford Impresses
Plus, Thursday was a solid day for nearly all sectors of the market, though Peloton Interactive pulls back after posting results.
Markets Focused on Relief Package, Price Is No Longer Truth, 'Unhedged Funds'
Let's not kid ourselves that there is any longer some kind of relationship between price and value. Or fact and truth.
Johnson & Johnson Rates Higher Price Targets Based on Its Charts
Buyers of the healthcare giant's shares have been more aggressive as the company pushes to launch its own Covid-19 vaccine.
Underperforming Transports, Vaccine Delivery, FOMC Statement, 3 Trading Thoughts
Wednesday afternoon the Fed's Federal Open Market Committee will publish the central bank's first official policy statement of 2021.
Keep Your Eyes on the Speculation Sideshow
I can't say when the market's B-movie will matter, but here's what I can tell you based on the indicators.
Whoa Baby! Here's How I'm Trading Johnson & Johnson After Earnings
The revenue and earnings beats are nice but that's not what really got me fired up.
Could Johnson & Johnson Go Higher and Higher?
Will the vaccine will be a game changer? The charts are giving indications that J&J is ready to run.
Youth Gone Wild, The Swarm of Individual Traders, GameStop, Melvin Capital
As a trader who at times takes short positions, I don't know whether to stand up and applaud this group or to fear them.
Jim Cramer: This Is a Market of Stocks, Not a Stock Market
With few exceptions, there isn't a stock that could bring down this market.
General Electric Isn't Out of the Woods Yet, Here's How I'd Trade it
GE remains a cash flow based story, but I see two negatives.
Volatile Road Ahead, 4 Market Impact Thoughts, Monster Earnings Week
What can be done? Well for one, we are going to have to be creative. Jay, and Janet, I need you both paying attention here.
